In the last few years, the deeply frustrating medical area of chronic migraine prevention has been revolutionized thanks to the discovery that a protein called calcitonin gene-related peptide, or CGRP, plays a role in the condition.
A new in vitro and in vivo study illustrates how a protease-activated receptor entering cells leads to pain and inflammation and how blocking it holds promise for treating colitis.